The UFO (Ultra Processed Foods in Obesity) Project
Launched by FEDERICO II UNIVERSITY · Sep 21, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The UFO (Ultra Processed Foods in Obesity) Project is a clinical trial aimed at understanding how eating ultra-processed foods (like sugary snacks and fast food) might be linked to obesity and metabolic syndrome in children and teenagers. With childhood obesity affecting millions of kids worldwide, this study will look at how these foods could be contributing to health problems that can shorten life expectancy. The trial will include participants aged 6 to 18 years who are either diagnosed with obesity, have obesity along with metabolic syndrome, or are healthy controls of the same age and sex.
To participate, children must be of Caucasian ethnicity and fall within the age range specified. They should not have any serious health conditions or recent illnesses that could affect the study. If eligible, participants can expect to take part in assessments that examine their eating habits and health. This research could help us better understand the effects of diet on childhood obesity and inform future strategies to improve children's health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Caucasian ethnicity, both sexes, age ≥6 and ≤18 years, diagnosis of obesity (Group 1), diagnosis of obesity and Metabolic Syndrome (Group 2), and age- and sex-matched healthy controls (Group 3).
- Exclusion Criteria:
- • Non-Caucasian ethnicity;
- • Age \<6 or \>18 years;
- • Concomitant presence of chronic diseases, neoplasms, immunodeficiencies, chronic infections,autoimmune diseases, chronic inflammatory bowel disease, celiac disease, metabolic-genetic diseases, cystic fibrosis and other chronic lung diseases, cardiovascular/respiratory/gastrointestinal malformations, neuropsychiatric disorders, and neurological disorders;
- • Intake of antibiotics and/or pre/pro/synbiotics;
- • History of obesity surgery and onset of diarrhea or acute gastrointestinal illness during the 12 weeks prior to enrollment;
- • Presence of tattoos, scars, moles or special lesions on both forearms.
About Federico Ii University
Federico II University, located in Naples, Italy, is a prestigious academic institution with a strong emphasis on advanced research and clinical innovation. As a clinical trial sponsor, the university is committed to fostering the development of novel therapeutic interventions and enhancing patient care through rigorous scientific inquiry. With a multidisciplinary approach, Federico II University collaborates with healthcare professionals, researchers, and industry partners to conduct high-quality clinical trials that adhere to ethical standards and regulatory requirements. Its dedication to improving health outcomes is reflected in its robust research programs and commitment to translating scientific findings into clinical practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Naples, , Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials